ASI develops image analysis & diagnostic tools for clinical and research applications. The company's GenASIs platform integrates within the existing workflow of the microscope and LIS framework, improving upon the lab's capabilities by providing a turn-key solution capable of slide capture, image analysis, case report and sign-out. With ASI, labs achieve higher throughput and enhanced clinical results based on accurate, reproducible and standardized analysis.
ASI specializes in cytogenetic and pathology applications, and currently supports brightfield and fluorescent microscopes for karyotype, in-situ hybridization (ISH) and immuno-histochemistry (IHC) applications. And with our unique capabilities in HyperSpectral imaging, ASI is also the leading supplier of spectral imaging microscopes to research labs around the globe.
Via an array of modular add-on tools which increase functionality and efficiency, ASI offers a custom-fit solution to any sized lab.
Established in 1993, ASI has over 30 registered patents, is supported by a worldwide network of 50 distributors and has supplied thousands of systems to labs across the globe. The GenASIs platform is FDA cleared for multiple clinical applications.